About Oxford Biomedica Solutions
Oxford Biomedica Solutions is a Healthcare company based in Bedford (United States) founded in 2022. Oxford Biomedica Solutions is a CDMO focused on manufacturing AAV cell and gene therapy products. It operates on a B2B model. Its focus areas include Biotechnology, Gene Therapy and Manufacturing. Its competitors include VectorBuilder, Genezen and Ascend; 2 of its 3 listed competitors have raised funding.
Company details
Oxford Biomedica Solutions oxford biomedica solutions is a cdmo focused on manufacturing aav cell and gene therapy products, focusing on providing healthcare solutions, advancing biotech innovations, gene therapy, and producing manufactured goods. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Bedford, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oxbsolutions.com
- Social LinkedIn
People of Oxford Biomedica Solutions
37 people are tracked at Oxford Biomedica Solutions (15 in leadership, 22 in team).
| Name | Role | Group |
|---|---|---|
Volker Glidden | Director Of Information Technology | Leadership |
Tim Kelly | CEO | Leadership |
Melissa P. | Director Of Finance Accounting And Financial Reporting | Leadership |
Kelly Quesada | Senior Vice President | Leadership |
Marissa Stanvick | Director | Leadership |
Ashish Sharma | Associate Director | Leadership |
Jin Yin | VP Process Development | Leadership |
Hannah Boss | Associate Director | Leadership |
Jon Duffty | Associate Director Facilities Operations | Leadership |
Aisleen McColl-Carboni | Senior Director | Leadership |
Stephen Boyd | Director Of Engineering | Leadership |
Patricia Daggett | Director Brand And Marketing | Leadership |
Diane Golebiowski | Director AAV Platform Development | Leadership |
Ryan Dickerson | Associate Director, CMC Portfolio Lead | Leadership |
David Hamilton | Director Warehouse Operations | Leadership |
Vincent Leonard Thari | Research Associate II | Team |
Samuel Adjei | Scientist 1 Analytical Development Computational Biology | Team |
Christopher Smith | Senior Scientist Analytical Development | Team |
Rudenc Lushi (Deni) | Scientist I Analytical Development | Team |
Kelly Walsh | Scientist II | Team |
17 more people are available in the full profile.
Complete people profiles for Oxford Biomedica Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Oxford Biomedica Solutions
Oxford Biomedica Solutions has 3 listed competitors in our database, 2 of them funded. They include VectorBuilder, Genezen and Ascend.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vectorbuilder.com | 2014 | Chicago, United States | $57.15M | Custom vector design, cloning, and virus packaging are offered online. | ||
| genezen.com | 2014 | Indianapolis, United States | CDMO focused on manufacturing of viral vector products | |||
| useascend.com | 2021 | Palo Alto, United States | $35.5M | 39 | Online insurance payments and premium financing are enabled for businesses. |
Detailed competitors of Oxford Biomedica Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Oxford Biomedica Solutions (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oxford Biomedica Solutions
Complete news archive for Oxford Biomedica Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxford Biomedica Solutions
Oxford Biomedica Solutions was founded in 2022.
Oxford Biomedica Solutions is headquartered in Bedford, United States.
Oxford Biomedica Solutions oxford biomedica solutions is a cdmo focused on manufacturing aav cell and gene therapy products, focusing on providing healthcare solutions, advancing biotech innovations, gene therapy, and producing manufactured goods. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Oxford Biomedica Solutions's top competitors include VectorBuilder, Ascend and Genezen.